Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis

被引：0
|
作者：
B. Jönsson
O. Ström
J. A. Eisman
A. Papaioannou
E. S. Siris
A. Tosteson
J. A. Kanis
机构：
[1] Stockholm School of Economics,Geriatrics and Medicine
[2] McMaster University,undefined
来源：
Osteoporosis International | 2012年 / 23卷
关键词：
Public Health; Osteoporosis; Relative Risk; Base Case; Case Scenario;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2063 / 2065
页数：2
相关论文
共 50 条
  • [1] Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Stroem, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (07) : 2063 - 2065
  • [2] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Strom, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 967 - 982
  • [3] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    Osteoporosis International, 2011, 22 : 967 - 982
  • [4] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Choo, Y. W.
    Mohd Tahir, N. A.
    Mohamed Said, M. S.
    Li, S. C.
    Makmor Bakry, M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (09) : 1909 - 1923
  • [5] COST-EFFECTIVENESS OF DENOSUMAB IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN SCOTLAND
    Davies, A.
    Compston, J.
    Ferguson, S.
    McClosky, E.
    Shearer, A.
    Taylor, A.
    VALUE IN HEALTH, 2011, 14 (07) : A310 - A310
  • [6] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Y. W. Choo
    N. A. Mohd Tahir
    M. S. Mohamed Said
    S. C. Li
    M. Makmor Bakry
    Osteoporosis International, 2022, 33 : 1909 - 1923
  • [7] COST-EFFECTIVENESS COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Ding, Y.
    Hay, J.
    VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [8] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Johnson, Ben
    Lai, Edward Chia-Cheng
    Ou, Huang-tz
    Li, Hong
    Stollenwerk, Bjorn
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [9] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Ben Johnson
    Edward Chia-Cheng Lai
    Huang-tz Ou
    Hong Li
    Björn Stollenwerk
    Archives of Osteoporosis, 2021, 16
  • [10] Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Boonen, Annelies
    Dirksen, Carmen D.
    Ben Sedrine, Wafa
    Reginster, Jean-Yves
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 19 - 28
12345